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408Objective: The objective of this study was to create a novel animal model to foster the future development of
interventional techniques for a cavocaval connection that mimics a Fontan completion.
Methods: Ten sheep were studied. All had the superior vena cava–right atrium junction closed using a polyte-
trafluoroethylene membrane. Avalveless Gore-Tex conduit connecting the terminal portion of the superior vena
cava to the right atrium was used to bypass the polytetrafluoroethylene occlusion and to allow normal venous
drainage through the right atrium. Radio-opaque nitinol rings were placed around the inferior vena cava near
its entry in the right atrium to allow better fluoroscopic visualization and to enhance stent stability during trans-
catheter cavocaval connection.
Results: The first 3 animals died during the learning curve as a result of technical issues. The subsequent 7 sur-
viving sheep showed good flow dynamics on cardiac catheterization. Transcatheter cavocaval connection was
performed successfully performed in 6 sheep at 0 to 9 months after the initial surgery. Sacrifice was done elec-
tively in all animals at 1 to 9 months per protocol. One animal was euthanized early because of an untreatable
infection. One sheep was observed as a control without a transcatheter cavocaval connection and was sacrificed
at 12 months.
Conclusions: A novel, chronic ovine model to foster development of transcatheter techniques for cavocaval
connection to mimic a Fontan completion was created. The successful model is easily reproducible after a short
learning curve and shows good survival. (J Thorac Cardiovasc Surg 2013;146:408-12)Children with functional univentricular hearts face
remarkable challenges during their lifetime. The develop-
ment of the Fontan operation has improved survival
significantly beyond the fourth decade; however, multiple,
staged surgeries affect postoperative quality of life nega-
tively in such patients. The complexity and the broad scope
of improvement of the univentricular heart have inspired
some highly creative surgical techniques to prepare the
heart for subsequent transcatheter repair.1-10 The interest
to perform transcatheter completion of Fontan stems
from the need to reduce the number of surgeries in these
patients. The interventional armamentarium with the
advent of stents has revolutionized the field of
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The Journal of Thoracic and Cardiovascular Surghas evolved from simple a bailout of a stenosis
or obstruction to an alteration of flow dynamics to
achieve optimal physiology. Despite several experimental
studies published on the development of surgical
preparation and transcatheter Fontan completion, there is
conspicuous lack of data on the creation of a viable,
chronic animal model for testing transcatheter techniques
for cavocaval connection in Fontan completion. The
nonviable models reported in the past failed to show
long-term assessment of the surgical pathway.7,8 Delayed
and long-term complications such as thrombus
formation, device fracture, failure, and so forth, remain
unstudied.
We report the feasibility for creating a chronic, viable
ovine heart model. Our studywas intended to simulate a sur-
gical substrate of partial cavopulmonary circulation and to
describe the challenges faced during the evolution and cre-
ation of the surgical model that may allow development and
long-term assessments of newer techniques for transcath-
eter cavocaval connection.
METHODS
Our study was performed in accordancewith theGuidelines for the Care
and Use of Laboratory Animals and was approved by the Subcommittee on
Research Animal Care and the local institutional ethics committee (INRA,
Paris, France).11 All animals received humane care in compliance with the
European Convention on Animal Care.ery c August 2013
Abbreviations and Acronyms
IVC ¼ inferior vena cava
PA ¼ pulmonary artery
PTFE ¼ polytetrafluoroethylene
RA ¼ right atrium
SVC ¼ superior vena cava
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SSurgical Technique
Ten consecutive sheep were studied after improvisation of surgical tech-
nique from an earlier experience. Standard premedication, anesthesia in-
duction, endotracheal intubation, and ventilation were achieved in all
sheep. Anesthesia was maintained with 2% halothane. The heart was ex-
posed through a conventional right thoracotomy and no extracorporeal cir-
culation was used. All sheep underwent total interruption of the superior
vena cava (SVC)–right atrium (RA) junction by a polytetrafluoroethylene
(PTFE) membrane. A nitinol wire was preshaped to an open ring and sized
with approximation to fit the inferior vena cava (IVC) snuggly. Two open
nitinol rings were placed around the IVC distal to the opening of the hepatic
veins and near its entry to the RA. The rings served as radio-opaque
markers for precise placement as well as an anchor of a covered stent for
subsequent transcatheter completion. All sheep underwent placement of
a valveless Gore-Tex conduit that connected the terminal portion of the
SVC to the RA to divert and bypass the PTFE occlusion and allow normal
venous drainage.(Figure 1, D).
Transcatheter Completion
We planned to perform transcatheter completion at 1, 3, 6, and 9 months
after the initial surgery. One animal was planned as a control with no trans-
catheter completion. The technique of completion has been reported previ-
ously.8 Briefly, cardiac catheterization was performed using both the right
femoral and internal jugular veins. A catheter was placed in contact with
the membrane separating the SVC and the RA. The stiff end of a guidewire
was pushed through the membrane. After perforation of the membrane,
a balloon catheter was inflated at the level of the membrane. Several cov-
ered stent grafts mounted on a 22-mm balloon catheter were deployed to
bridge the gap between the opened SVC and the radio-opaque nitinol rings
at the IVC-RA junction. Selective angiographies were performed to con-
firm the absence of flow from the SVC to the RA, after reestablishing
the pathway between the SVC and the RA, and after transcatheter cavo-
caval connection.
Sacrifice
Per study protocol, euthanasia was planned at 1, 3, 6, and 9 months after
completion, or at 12months after surgical preparation in the animal without
transcatheter completion.RESULTS
Ten sheep were used in the study. The first 3 died early as
a result of technical issues. Two died from hypovolemic
shock secondary to uncontrolled hemorrhage (accidental
rupture of anastomosis) before transcatheter completion
and 1 died from SVC syndrome as a result of occlusion of
the SVC-RA connection after transcatheter completion.
The remaining 7 sheep survived the operative procedure
and recovered uneventfully. All animals except one under-
went transcatheter cavocaval completion at 0 to 9 months
after surgery. All animals except one survived transcatheterThe Journal of Thoracic and Cacompletion and were followed 1 to 9 months after the com-
pletion (median, 5 months). One animal experienced fever,
weight loss and poor feeding after completion secondary to
a fulminating infection. The animal was euthanized after 1
week of ineffective treatment with antibiotics. The uncom-
pleted animal was left alive and euthanized 1 year after the
initial surgery. Early and late catheterization was done in all
surviving sheep and all demonstrated good flow dynamics,
with a mean gradient across the SVC pathway between
0 mm Hg and 2 mm Hg.
Cardiac catheterization during the completion steps with
assessment of patency of the SVC-RA connection, PTFE
membrane perforation, and thus reestablishment of the na-
tive SVC-RA connection is highlighted in Figure 2. Subse-
quent angiographic views after completion showing the
covered stents connecting the SVC and the IVC, with redi-
rection of IVC flow, are presented in Figure 3.
All sheep (except the one described previously) eutha-
nized per protocol demonstrated good health at the time
of sacrifice. At macroscopic examination, no thrombus
was found at the SVC-RA junction, which remained widely
open. In completed animals, all stents were patent with no
leakage or thrombus formation (Figure 4). No thrombus
was noted in the lungs.
DISCUSSION
Hausdorf and colleagues1,2 were the first to attempt and
describe transcatheter completion of a hemi-Fontan using
balloon dilatation of the banded cavoatrial junction and fen-
estration closure using either a covered stent or patent
ductus arteriosus occluders. Subsequently, Klima and col-
leauges3 developed a new approach by establishing bidirec-
tional Glenn circulation and subtotal banding of the SVC at
the cavoatrial junction, along with PTFE cuff placement
around the IVC—all performed in the absence of cardiopul-
monary bypass. To facilitate placement of the graft stent in
the SVC-RA junction, and to avoid residual obstruction
around the SVC band site, Galantowicz and Cheatham4,5
closed the SVC-RA junction by using a pericardial patch
for a subsequent intracardiac stent. Konstantinov and
others6,7 modified this further by placing stents at the
level of both atriocaval junctions. The atrial SVC was
then connected to the inferior face of the unopened right
pulmonary artery (PA). The stent at the SVC–PA junction
may cover a part of the PA lumen and thus reduce the
forward flow. With kinetic energy as the only force to
drive the blood in a circuit with resistance in series, and
absent a driving pump, any degree of loss of energy
reduces cardiac output and vital organ perfusion.
Despite such promising preliminary results of transcath-
eter completion of Fontan, there are some unanswered ques-
tions about the ideal surgical technique to prepare
a univentricular heart for subsequent transcatheter tech-
niques. The insertion of foreign material inside the heart,rdiovascular Surgery c Volume 146, Number 2 409
FIGURE 1. Schematic drawings showing all techniques used for the creation of a simulated cavopulmonary sheep heart model. This study presents only the
results from view D. Techniques depicted in views A through C resulted in 100% mortality.
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Salong with the iatrogenic dead space, may favor thrombus
formation. Given the fact that univentricular hearts have
open connection between the right and left circulation,
any thrombus formation in any chamber can be cata-
strophic. There is a growing need to have a chronic animal
heart model to assess such potential complications and the
long-term outcomes of transcatheter techniques. In our
prior experience we tested various surgical models to simu-
late Fontan physiology (data not shown). The surgical tech-
niques used included placement of a valveless conduit
between the SVC and the main PA; side-to-side bicaval
branch PA anastomosis, with the right upper PA branch
anastomosed to the SVC and the right lower lobar branch
anastomosed to the IVC; and total cavopulmonary bypass
with a valveless synthetic Y tube between the 2 vena cava
and the main pulmonary artery.
Creation of such surgical models with physiologic simu-
lation of cavopulmonary circulation was highly eventful
with no survival beyond 2 hours of surgery (Figure 1, A,
B, and C). It was realized that animals would not tolerate
bypassing the right ventricle even for a couple hours. To cir-
cumvent the problems noted with our early experience, we
modified our surgical approach significantly and developed
an anatomic model as a platform to test the technical feasi-
bility and the long-term outcomes of transcatheter cavo-
caval connection for Fontan completion (Figure 1, D).FIGURE 2. Angiographic views showing the perforation steps of the Fontan c
animal. The superior vena cava has been connected to the right atrium. The nor
fluoroethylene membrane. Two rings have been placed around the superior vena c
is shown here). B, Perforation of themembranewith a needle. C, Dye injection in
superior vena cava and the right atrium.
410 The Journal of Thoracic and Cardiovascular SurgThe model from the current study was therefore designed
to redirect flow without altering the cardiac architecture
or physiology. The results were spectacular and allowed
us to test the completion of the cavocaval connection chron-
ically in all animals per protocol.
Clinical Implications
We believe our surviving animal anatomic model closely
mimics the pre-Fontan preparatory stage of a univentricular
heart from an interventional standpoint. The uniform sur-
vival with only planned deaths after a short learning curve
makes this a good and a reproducible technique. This work-
ing model should be suitable to test various transcatheter
therapies, including the possibility of hybrid therapies in
the future.9,10 With greater experience it may be possible
to create a hybrid strategy with the current model to
accomplish intraoperative completion of Fontan in the
same setting with significant reduction of crossclamp time
and perioperative mortality. We believe this is the only
pathway that works well and has good long-term survival.
All attempts to create a real-life anatomic and physiologic
cavopulmonary connection failed with 100% mortality.
The current model proved to be ideal in testing various
transcatheter therapies for completion. Each step of the sur-
gical preparation and the subsequent transcatheter comple-
tion can be tested with reliable accuracy, including surgicalompletion. A, Preliminary dye injection shows the surgical pathway in the
mal superior vena cava–right atrium connection is occluded by a polytetra-
ava at the level of themembrane and 2 around the inferior vena cava (only 1
the sheath after perforation shows the reestablished connection between the
ery c August 2013
FIGURE 3. Angiographic views after completion. A, Covered stents have been placed between the superior vena cava and the inferior vena cava. Dye
injection in the superior vena cava shows the connection to the right atrium. B, Dye injection in the inferior vena cava shows the contrast going into the
covered stents in the superior vena cava connection.
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Screation of superior connection, placement of markers
around the IVC, pliability of the SVC-RA PTFE membrane
for various perforation techniques and transcatheter open-
ing of the occluded SVC, and covered stent placement.
Moreover, because it is a viable model without significant
physiologic alterations, long-term complications can also
be assessed and may include thrombus formation secondary
to a foreign body and dead space; complications of stent
fracture, migration, and dislodgment; damage to the IVC
and neighboring structures; impact of the tendinous inser-
tion of the diaphragm at the caval opening with its dynamic
motion on the stent; and paraprosthetic leak.
Study Limitations
The model we created is not a physiologic model of Fon-
tan circulation because all animals had structurally normalFIGURE 4. Gross examination of the heart after sacrificing the animal. A, The c
cava (IVC). B, The connection between the SVC and the right atrium after retr
The Journal of Thoracic and Cahearts with a well-developed right ventricle pumping the
right circulation. However, it is a good simulated platform
to test various transcatheter and hybrid techniques. The po-
tential of thrombus formation in the long run still cannot be
ruled out completely; however, none of the surviving sheep
had any thrombus formation as of the last follow-up. More-
over, for future clinical applications, a definitive anticoagu-
lation strategy may be required that was not used in any of
our animals.
CONCLUSIONS
We describe new surgical technique for the preparation
for an anatomic ovine heart model for transcatheter comple-
tion of Fontan circulation. This surgical technique was eas-
ily reproducible after a short learning curve with no major
limitations. The novel and successful creation of a viableovered stent running from the superior vena cava (SVC) to the inferior vena
ieval of the IVC stent (***).
rdiovascular Surgery c Volume 146, Number 2 411
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Sovine heart model marks a new milestone in allowing fur-
ther evaluation of transcatheter and hybrid techniques in
univentricular hearts. Additional long-term studies with
this model may be required before it may be implemented
clinically.
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